These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18538190)

  • 1. Problems with implantable cardiac device therapy.
    Kowalski M; Huizar JF; Kaszala K; Wood MA
    Cardiol Clin; 2008 Aug; 26(3):441-58, vii. PubMed ID: 18538190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmia detection in single- and dual-chamber implantable cardioverter defibrillators: the more leads, the better?
    Francia P; Balla C; Uccellini A; Cappato R
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1077-82. PubMed ID: 19500231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The complications of implantable cardioverter-defibrillators and their treatment].
    Iorio D; Bonifazi R; Aquino TM; Santise G; Spampinato N
    G Chir; 1999 May; 20(5):238-40. PubMed ID: 10380366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
    Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
    Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU).
    Rosso R; Glick A; Glikson M; Wagshal A; Swissa M; Rosenhek S; Shetboun I; Khalamizer V; Fuchs T; Boulos M; Geist M; Strasberg B; Ilan M; Belhassen B;
    Isr Med Assoc J; 2008 Jun; 10(6):435-9. PubMed ID: 18669142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia induced T wave oversensing leading to loss of biventricular pacing and inappropriate ICD shocks.
    Koul AK; Keller S; Clancy JF; Lampert R; Batsford WP; Rosenfeld LE
    Pacing Clin Electrophysiol; 2004 May; 27(5):681-3. PubMed ID: 15125731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
    Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
    Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of cardiac tachyarrhythmias in implantable devices.
    Gillberg J
    J Electrocardiol; 2007; 40(6 Suppl):S123-8. PubMed ID: 17993309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections of implantable cardioverter-defibrillators: frequency, predisposing factors and clinical significance.
    Gil P; Fernández Guerrero ML; Bayona JF; Rubio JM; de Górgolas M; Granizo JJ; Farré J
    Clin Microbiol Infect; 2006 Jun; 12(6):533-7. PubMed ID: 16700701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter defibrillators and their role in heart failure progression.
    Cevik C; Perez-Verdia A; Nugent K
    Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of outcomes for patients receiving implantable cardioverter defibrillators for primary vs secondary-prevention.
    Giedrimas A; Giedrimiene D; Guertin D; White CM; Clyne CA; Kluger J
    Conn Med; 2008; 72(6):329-33. PubMed ID: 18610705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.